Evidence map›Paper›PMID 40811032›Full record

ArticleJCI insight2025

Photon and particle radiotherapy induce redundant modular chemotaxis of human lymphocytes.

Joscha A Kraske, Michael M Allers, Aleksei Smirnov, Bénédicte Lenoir, Azaz Ahmed, Meggy Suarez-Carmona, Mareike Hampel, Damir Krunic, Alexandra Tietz-Dalfuß, Tizian Beikert and 14 more

Abstract read
In one paragraph

Article in JCI insight, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Adaptive resistance in cancer immunotherapy.Cellular & molecular immunology · 2026
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Joscha A KraskeDepartment of Medical Oncology, National Center for Tumor Diseases (NCT), and.
Michael M AllersDepartment of Radiation Oncology, Heidelberg University Hospital, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.
Aleksei SmirnovDepartment of Radiation Oncology, Heidelberg University Hospital, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.
Bénédicte LenoirClinical Cooperation Unit Applied Tumor Immunity and.
Azaz AhmedDepartment of Medical Oncology, National Center for Tumor Diseases (NCT), and.
Meggy Suarez-CarmonaDivision of Translational Immunotherapy, DKFZ, Heidelberg, Germany.
Mareike HampelClinical Cooperation Unit Applied Tumor Immunity and.
Damir KrunicLight Microscopy Facility, DKFZ, Heidelberg, Germany.
Alexandra Tietz-DalfußDepartment of Radiation Oncology, Heidelberg University Hospital, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.
Tizian BeikertDepartment of Radiation Oncology, Heidelberg University Hospital, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.
Jonathan M SchneeweissDepartment of Radiation Oncology, Heidelberg University Hospital, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.
Stephan BronsHeidelberg Ion Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
Dorothee AlbrechtDepartment of Radiation Oncology, Heidelberg University Hospital, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.
Thuy TrinhDepartment of Radiation Oncology, Heidelberg University Hospital, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.
Muzi LiuDepartment of Radiation Oncology, Heidelberg University Hospital, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.
Nathalia A GieseDepartment of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Medical Faculty Heidelberg, Heidelberg University, Germany.
Christin GlowaDepartment of Radiation Oncology, Heidelberg University Hospital, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.
Jakob LiermannDepartment of Radiation Oncology, Heidelberg University Hospital, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.
Ramon Lopez PerezDepartment of Radiation Oncology, Heidelberg University Hospital, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.
Dirk JägerDepartment of Medical Oncology, National Center for Tumor Diseases (NCT), and.
Jürgen DebusDepartment of Radiation Oncology, Heidelberg University Hospital, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.
Niels HalamaDepartment of Medical Oncology, National Center for Tumor Diseases (NCT), and.
Peter E HuberDepartment of Radiation Oncology, Heidelberg University Hospital, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.
Thomas WalleDepartment of Medical Oncology, National Center for Tumor Diseases (NCT), and.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radiotherapy triggers chemokine release and leukocyte infiltration in preclinical models through activation of the senescence-associated secretory phenotype (SASP). However, effects of irradiation on senescence and SASP in human tissue and in the context of particle radiotherapy remain unclear. Here, we analyzed chemokine patterns after radiotherapy of human pancreatic tumors and cancer cell lines. We show that irradiated tumor cells coexpressed SASP chemokines in defined modules. These chemokine modules correlated with infiltration of distinct leukocyte subtypes expressing cognate receptors. We developed a patient-derived pancreatic tumor explant system, which verified our identified radiation-induced chemokine modules. Chemokine modules were partially conserved in cancer cells in response to photon and particle irradiation, showing a dose-dependent plateau effect, and induced subsequent migration of NK and T cell populations. Hence, our work reveals redundant interactions of cancer cells and immune cells in human tissue, suggesting that targeting multiple chemokines is required to efficiently perturb leukocyte infiltration after photon or particle radiotherapy.

Indexed as

ChemotaxisLymphocytesPancreatic NeoplasmsPhotonsCell Line, TumorCellular SenescenceChemokinesHumansChemokinesCellular senescenceChemokinesImmunologyOncologyRadiation therapy

Identifiers

PMID40811032
PMCPMC12487834

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.